ArticleJournal of atherosclerosis and thrombosis2021

Pemafibrate, A Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator, Reduces Plasma Eicosanoid Levels and Ameliorates Endothelial Dysfunction in Diabetic Mice.

Kumiko Suto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.